SCHEMBL2817040

SCHEMBL2817040

CC[C](O)C1CNCCO1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 8/20 0.41
SLC6A2 P23975 7/20 0.38
SLC6A4 P31645 5/20 0.38
SLC6A3 Q01959 4/20 0.38
ADRB2 P07550 2/20 0.38
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
ADRA1A P35348 1/20 0.38
HTR2B P41595 1/20 0.38
ADRA2C P18825 1/20 0.35
REN P00797 1/20 0.33
MLNR O43193 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR2C P28335 1/20 0.33
OPRK1 P41145 1/20 0.33
KCNH2 Q12809 1/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6039543 0.83 SSTR4 (0.42) SSTR4SLC6A2SLC6A4SLC6A3ADRB2
SCHEMBL23230712 0.82 SSTR4 (0.44) SSTR4SLC6A2SLC6A4REN
SCHEMBL3308454 0.82 SSTR4 (0.38) SSTR4SLC6A2SLC6A4SLC6A3ADRB2
SCHEMBL295081 0.82 SSTR4 (0.44) SSTR4SLC6A2SLC6A4REN
SCHEMBL27829000 0.80
SCHEMBL3308771 0.77 SSTR4 (0.38) SSTR4SLC6A2SLC6A4SLC6A3ADRB2
SCHEMBL3308779 0.77 SSTR4 (0.38) SSTR4SLC6A2SLC6A4SLC6A3ADRB2
SCHEMBL6039632 0.77 SSTR4 (0.39) SSTR4SLC6A2SLC6A4REN
SCHEMBL2643368 0.77
SCHEMBL5461286 0.77 SSTR4 (0.41) SSTR4SLC6A2RENDRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010110686-A1 PYRIMIDINYL AND 1,3,5 TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY PATHWAY THERAPEUTICS LIMITED (NZ) 2010-09-30 WO claimed
WO-2010110686-A1 PYRIMIDINYL AND 1,3,5 TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY PATHWAY THERAPEUTICS LIMITED (NZ) 2010-09-30 WO disclosed